肺纤维化:从机制到治疗方法
Mengna Jiang1, Wenxia Bu1, Xuehai Wang1
1Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong, 226019, China.
Journal of translational medicine
|May 9, 2025
概括
肺纤维化 (PF) 治疗面临副作用和输送问题的挑战. 本综述探讨了新的治疗目标和药物输送策略,以获得更好的PF治疗结果.
科学领域:
- 肺部医学 肺部医学
- 纤维性疾病 纤维性疾病
- 药物输送系统 药物输送系统
背景情况:
- 肺纤维化 (PF) 是一种进展性肺部疾病,其特征是细胞外基质沉积过多和纤维细胞增殖.
- 已知的原因包括环境污染物,吸烟,衰老和感染.
- 目前FDA批准的抗纤维素药物 (皮尔费尼,尼丁达尼布) 由于副作用和不高效的输送而存在局限性.
研究的目的:
- 审查肺纤维化的致病机制.
- 讨论治疗药物向PF的信号通路.
- 突出 PF 治疗的有希望的药物输送策略.
主要方法:
- 关于PF的病原机制的文献综述.
- 对当前和新兴治疗点的分析.
- 对PF的新型药物输送方法的评估.
主要成果:
- PF的病原体涉及复杂的信号通路驱动纤维化.
- 针对特定的途径显示出抗纤维菌作用的潜力.
- 先进的药物输送系统可以提高治疗效率并减少副作用.
结论:
- 对于改善PF的治疗目标和输送方法,有极大需求.
- 针对分子途径和利用创新的药物输送系统是推动PF治疗的关键.
- 对这些领域的进一步研究对于改善患者预后至关重要.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
106
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
106
COPD: Pathogenesis and Clinical Features
179
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
179
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
109
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
109
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Other Pulmonary Disorders
784
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
784


